kynurenic acid has been researched along with Disease Exacerbation in 6 studies
Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Increased oxidative stress (SOX), inflammation and accelerated atherosclerosis have been reported in end-stage renal disease (ESRD), but their associations with kynurenine pathway activation remain unknown." | 3.75 | Kynurenine, quinolinic acid--the new factors linked to carotid atherosclerosis in patients with end-stage renal disease. ( Brzosko, S; Mysliwiec, M; Pawlak, D; Pawlak, K, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y | 1 |
| Zhang, J | 1 |
| Yang, Y | 1 |
| Xiang, K | 1 |
| Li, H | 1 |
| Sun, D | 1 |
| Chen, L | 1 |
| Liu, JJ | 1 |
| Ching, J | 1 |
| Wee, HN | 1 |
| Liu, S | 1 |
| Gurung, RL | 1 |
| Lee, J | 1 |
| M, Y | 1 |
| Zheng, H | 1 |
| Lee, LS | 1 |
| Ang, K | 1 |
| Shao, YM | 1 |
| Kovalik, JP | 1 |
| Subramaniam, T | 1 |
| Sum, CF | 1 |
| Sharma, K | 1 |
| Kestenbaum, BR | 1 |
| Lim, SC | 1 |
| Curto, M | 1 |
| Lionetto, L | 1 |
| Fazio, F | 1 |
| Corigliano, V | 1 |
| Comparelli, A | 1 |
| Ferracuti, S | 1 |
| Simmaco, M | 1 |
| Nicoletti, F | 1 |
| Baldessarini, RJ | 1 |
| Jasiewicz, M | 1 |
| Moniuszko, M | 1 |
| Pawlak, D | 2 |
| Knapp, M | 1 |
| Rusak, M | 1 |
| Kazimierczyk, R | 1 |
| Musial, WJ | 1 |
| Dabrowska, M | 1 |
| Kaminski, KA | 1 |
| Pawlak, K | 1 |
| Brzosko, S | 1 |
| Mysliwiec, M | 1 |
| Saran, T | 1 |
| Hilgier, W | 1 |
| Urbańska, EM | 1 |
| Turski, WA | 1 |
| Albrecht, J | 1 |
1 review available for kynurenic acid and Disease Exacerbation
| Article | Year |
|---|---|
Kynurenine-3-monooxygenase (KMO): From its biological functions to therapeutic effect in diseases progression.
Topics: Disease Progression; Humans; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Neurodegenerati | 2022 |
5 other studies available for kynurenic acid and Disease Exacerbation
| Article | Year |
|---|---|
Plasma Tryptophan-Kynurenine Pathway Metabolites and Risk for Progression to End-Stage Kidney Disease in Patients With Type 2 Diabetes.
Topics: Diabetes Mellitus, Type 2; Disease Progression; Humans; Kidney Failure, Chronic; Kynurenic Acid; Kyn | 2023 |
Serum xanthurenic acid levels: Reduced in subjects at ultra high risk for psychosis.
Topics: Adolescent; Adult; Disease Progression; Female; Humans; Hydroxyindoleacetic Acid; Kynurenic Acid; Ky | 2019 |
Activity of the kynurenine pathway and its interplay with immunity in patients with pulmonary arterial hypertension.
Topics: Adult; Aged; Area Under Curve; Case-Control Studies; Disease Progression; Echocardiography, Doppler; | 2016 |
Kynurenine, quinolinic acid--the new factors linked to carotid atherosclerosis in patients with end-stage renal disease.
Topics: Adult; Age Factors; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Cross-Sectional Studies | 2009 |
Kynurenic acid synthesis in cerebral cortical slices of rats with progressing symptoms of thioacetamide-induced hepatic encephalopathy.
Topics: Animals; Cerebral Cortex; Disease Models, Animal; Disease Progression; Glutamic Acid; Hepatic Enceph | 2004 |